The enormous decline in the annual morbidity and mortality from malaria is the spectacular global public health success of the past decade. This achievement results largely from increased finance for investment in measures known to prevent malaria: bednets treated with long-lasting insecticides, chemoprophylaxis, and rapid access to effective treatment. Such has been the success of these measures that plans are being put in place to achieve the vision of a malaria-free world within the next three decades. Large financial and political commitments and ongoing research will be required to maintain the gains, overcome known and unknown challenges such as drug and insecticide resistance, and to achieve those goals. Effective vaccines or methods for reducing mosquito vectorial capacity would add enormously to the chance of achieving this goal. The aim of this article is to summarise the current status of malaria control, the recent research successes, the challenges being addressed, and the plan for progress to elimination of malaria in the longer term.
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Spectacular progress in reducing the burden of malaria
Funding for major efforts in implementation of known effective preventive measures in the past 15 years has caused an almost 40% reduction in incidence of malaria disease episodes. These measures, together with increased access to effective treatment, have led to a reduction in malaria death rates of 60% globally, and 71% in children under five 
The current situation
According to the latest information provided by the WHO,~1.2 billion people are at risk of malaria with the major burden of disease carried by young children and pregnant women living in endemic areas. 1 The burden of malaria is not evenly distributed across the world. 
Malaria elimination
The major progress already referred to is the result of implemen- As countries, or areas within countries, move towards elimination, the emphasis changes from population level data and disease control to intense surveillance for identification of individual infec- 
*
The emphasis on elimination draws attention to P. vivax, common outside Africa, and with separate challenges such as longterm relapses from hypnozoites, and transmission by vectors biting outdoors and during the daytime, which are therefore not amenable to the standard interventions for vector control.
Many considered that elimination would not be achieved without a major breakthrough such as effective vaccines to reduce morbidity and transmission, or a technology for vast reduction in vectorial capacity of Anopheles gambiae, the most efficient and important vector of P. falciparum in Africa.
It is a source of optimism that since the MalERA agenda was 
Under the Microscope
The challenges for malaria control and elimination
See Table 1 for a more comprehensive list. Some of the biological, societal and economic requirements for elimination are listed in Table 2 .
Artemisinin resistance
The time and mode of action of artemisinin are not well understood, and in vitro tests are not sufficiently developed and standardised to replace the requirement for in vivo testing for the presence of resistance. A warning sign, before emergence of clinical resistance, is the detection of delayed parasite clearance from the blood over the first few days of treatment. Because of the fear of emergence of resistance, combination therapy is essential, for example with piperaquine or lumefantrine, so the efficacy of partner drugs is also of great importance to ensure complete parasite clearance. Recently, drug resistance has been associated with some but not all mutations of the kelch gene in P. falciparum that will probably assist in mapping resistance 8, 9 . Melbourne-based researchers have developed synthetic artemisinin-like compounds, which are probably not susceptible to kelch-based resistance.
Insecticide resistance
Chemical resistance to insecticides is a well known threat. Strong 
Elimination as an approach to drug resistance in the Mekong region
Where artemisinin has been widely used in the Mekong region, delayed parasite clearance has been noted in many countries, and it is felt that in the absence of alternative drugs, the only appropriate approach is to eliminate malaria in the area where resistance has already been detected. Pilot studies have been initiated to test the feasibility of this approach 10 .
Fortunately, delayed parasite clearance due to artemisinin resistance has not yet been seen in parasites from India and Africa, but in the recent past, development of resistance to chloroquine or sulphadoxine/pyrimethamine accompanied by ongoing use of those drugs led to many unnecessary deaths. Under the Microscope
Elimination to eradication
The malaria eradication campaign of 50 years ago succeeded in eliminating malaria from many countries but did not achieve its goals in areas of most intense transmission such as heartland Africa.
However, many important lessons were learned about the need for community engagement, political will, intensive surveillance as a response, and the need for continued vigilance to prevent return of malaria to a now susceptible entire population that has benefited from a few years of interrupted transmission. As transmission declines and malaria-specific services are phased out, it is critical for awareness of the disease in all its manifestations to be retained at a high level in general services for detection, management, surveillance and response to any new episodes.
Lessons of the eradication campaign are being refreshed, for ex- Other major lessons of the eradication campaign were that research must continue throughout the programs to deal with new challenges, and that every country needs to develop the human resource capacity to deal with the multi-disciplinary approach to this grand challenge.
Recent vaccine breakthroughs; progress with P. falciparum but little progress with other species formation of a viral-like particle known as RTS,S. In recent very large trials, participants had good access to malaria prevention and rapid access to treatment, so mortality was low and no effect of vaccination on mortality could be detected. There was a concerning, but unexplained, slight increase in episodes of meningitis in the RTS,S arm, requiring further evaluation. A recent review of RTS,S by WHO recommended that the next step should be to initiate 3-5 pilot implementation studies 12 . Further analysis of trial data showed that the vaccine had higher efficacy against strains homologous to the vaccine, suggesting both a strain-specific as well as a strain-independent mechanism 13 . This vaccine is a very important first step but on its own, is unlikely to be the solution that is required.
Attenuated sporozoite vaccines
The most impressive of all malaria vaccine trial results are those achieved with intravenous inoculation of radiation-attenuated whole sporozoites in which up to 100% protection has been achieved in Phase 1 studies using multiple doses of vaccine 14 . Field studies in Mali and Tanzania have also demonstrated efficacy and further trials are planned to optimise dose and delivery schedule 14 .
Conclusion
With the spectacular reduction of the burden of malaria in the past 15 years, the time is ripe to re-double efforts both to prevent resurgence and to increase resources with the goal of achieving the health and economic benefits that would result from disease elimination. Major progress is being reported in developing the tools to add to current successful interventions from basic research into biology of hypnozoites and transition of gametocytes to sporozoites, to field trials of vaccines and innovations in surveillance and epidemiology. A multi-disciplinary response coupled with strong community engagement, and ongoing political and financial support will be required to maintain the current rate of decline in malaria, and hopefully achieve the ambitious goal of elimination.
